par 211 par 211 (Propafenone Extended Release 425 mg)

Pill imprint par 211 par 211 has been identified as Propafenone hydrochloride extended release 425 mg.

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substance Act (CSA).

Propafenone hydrochloride extended release

Imprint:

par 211 par 211

Strength:

425 mg

Color:

Red & White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Group I antiarrhythmics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Par Pharmaceutical Inc

National Drug Code (NDC):

49884-0211

Inactive Ingredients:

alcohol
lactose anhydrous
butyl alcohol
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
FD&C Yellow No. 6
ferrosoferric oxide
gelatin
magnesium stearate
povidone
propylene glycol
shellac
titanium dioxide
water
ethylcelluloses

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0547	AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.